FORMULATION AND EVALUATION OF ACECLOFENAC PRONIOSOME LOADED ORABASE FOR MANAGEMENT OF DENTAL PAIN
Objective: The main motive is to develop proniosomes loaded orabase for enhanced permeation and prolonged release of aceclofenac for oro dental conditions.
Methods: Various aceclofenac (ACL) proniosomal gels were formulated employing various surfactants, span 60 was superior and significant for loading into orabase. The formulations were scrutinized for entrapment efficiency, optical microscopy, in vitro diffusion and release studies, mucoadhesive strength, ex-vivo permeation studies and drug-excipient interactions were determined by FTIR spectroscopy.
Results: Considering best entrapment efficiency with span 60 (97.60Â±1.85) and optimum vesicle shape, along with prolonged drug permeation (45% for 24 h) the formulation F(ACL)1 was selected and optimized for loading into orabase. The F(ACL)1 loaded orabase exhibited significant prolonged release over 14 h, and permeation profiles exhibited nearly two-fold increased flux in comparison with control. Good mucoadhesive strength was observed for proniosomal orabase 6370 dynes/cm2. No evidence of incompatibility amongst formulation components from FTIR studies. SEM images revealed the particle size range from 136 Âµm to 236 Âµm for proniosomal orabase.
Conclusion: Orabase can be an effective carrier for proniosomes with enhanced permeation and prolonged release for oro-dental conditions.
2. Liliana L Jorge, Caroline C Feres, Vitor EP Teles. Topical preparations for pain relief: efficacy and patient adherence. J Pain Res 2011;4:11â€“24.
3. Shukla ND, Tiwari M. Proniosomal drug delivery systems: clinical applications. Int J Res Pharm Biomed Sci 2011;2:880-7.
4. Fang JY, Yu SY, Wu PC, Huang YB, Tsai YH. In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm 2001;215:91â€“9.
5. Alam MI, Baboota S, Kohli K, Ali J, Ahuja A. Pharmacodynamic evaluation of proniosomal transdermal therapeutic gel containing celecoxib. Scienceasia 2010;36:305-11.
6. Mokhtar M, Sammour OA, Hammad MA, Megrab NA. Impact of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes from proniosomes. AAPS PharmSciTech 2008;9:782-90.
7. Devaraj GN, Parakh SR, Devraj R, Apte SS, Rao BR, Rambhau D. Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol. J Colloid Interface Sci 2002;251:360â€“5.
8. Hanan Jalal Kassab, Lena Murad Thomas, Saba Abdulhadi Jabir. Development and physical characterization of a periodontal bioadhesive gel of gatifloxacin. Int J Appl Pharm 2017;9:31-6.
9. Choi HG, Jung JH, Ryu JM, Yoon SJ, Oh YK, Kim CK. Development of in situ gelling and mucoadhesive acetaminophen liquid suppository. Int J Pharm 1998;165:33-6.
10. Sezer AD, Cevher E, Hatipoglu F, Ogurtan Z, Bas AL, Akbuga J. The use of fucosphere in the treatment of dermal burns in rabbits. Eur J Pharm Biopharm 2008;69:189â€“98.
11. Bonacucina G, Martelli S, Palmieri GF. Rheological, mucoadhesive and release properties of Carbopol gels in hydrophilic cosolvents. Int J Pharm 2004;282:115â€“30.
12. Lalit Kumar, Ruchi Verma. Chemical stability studies of bioadhesive topical gel. Int J Pharm Pharm Sci 2011;3:101-4.
13. Ali J, Khar R, Ahuja A, Kalra R. Buccoadhesive erodible disk for treatment of oro-dental infections: design and characterisation. Int J Pharm 2002;238:93â€“103.
14. Thakur R, Anwer Md K, Shams MS, Ali A, Khar RK, Shakeel F, et al. Proniosomal transdermal therapeutic system oflosartan potassium: development and pharmacokinetic evaluation. J Drug Targeting 2009;17:442-9.
15. Ankit Acharya, Kiran Kumar GB, Mohammed Gulzar Ahmed, Saroj Paudel. A novel approach to increase the bioavailability of candesartan cilexetil by proniosomal gel formulation: in vitro and in vivo evaluation. Int J Pharm Pharm Sci 2016;8:241-6
16. Hao Y, Zhao F, Li N, Yang Y, Li K. Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm 2002;224:73-80.